120 related articles for article (PubMed ID: 17689900)
21. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
22. Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.
Gortzi O; Antimisiaris SG; Klepetsanis P; Papadimitriou E; Ioannou PV
Eur J Pharm Sci; 2003 Feb; 18(2):175-83. PubMed ID: 12594011
[TBL] [Abstract][Full Text] [Related]
23. A correlation between lipid domain shape and binary phospholipid mixture composition in free standing bilayers: A two-photon fluorescence microscopy study.
Bagatolli LA; Gratton E
Biophys J; 2000 Jul; 79(1):434-47. PubMed ID: 10866969
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical study of the protein-liposome interactions: influence of liposome composition and concentration on protein binding.
Foteini P; Pippa N; Naziris N; Demetzos C
J Liposome Res; 2019 Dec; 29(4):313-321. PubMed ID: 29685077
[TBL] [Abstract][Full Text] [Related]
25. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice.
Atyabi F; Farkhondehfai A; Esmaeili F; Dinarvand R
Acta Pharm; 2009 Jun; 59(2):133-44. PubMed ID: 19564139
[TBL] [Abstract][Full Text] [Related]
26. Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.
Gortzi O; Papadimitriou E; Kontoyannis CG; Antimisiaris SG; Ioannou PV
Pharm Res; 2002 Jan; 19(1):79-86. PubMed ID: 11837704
[TBL] [Abstract][Full Text] [Related]
27. Sterically stabilized liposomes production using staggered herringbone micromixer: Effect of lipid composition and PEG-lipid content.
Cheung CCL; Al-Jamal WT
Int J Pharm; 2019 Jul; 566():687-696. PubMed ID: 31212051
[TBL] [Abstract][Full Text] [Related]
28. In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features.
Mastrotto F; Brazzale C; Bellato F; De Martin S; Grange G; Mahmoudzadeh M; Magarkar A; Bunker A; Salmaso S; Caliceti P
Mol Pharm; 2020 Feb; 17(2):472-487. PubMed ID: 31789523
[TBL] [Abstract][Full Text] [Related]
29. Structural effects caused by spray- and freeze-drying of liposomes and bilayer disks.
Wessman P; Edwards K; Mahlin D
J Pharm Sci; 2010 Apr; 99(4):2032-48. PubMed ID: 19894278
[TBL] [Abstract][Full Text] [Related]
30. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
31. Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes.
Johansson E; Engvall C; Arfvidsson M; Lundahl P; Edwards K
Biophys Chem; 2005 Feb; 113(2):183-92. PubMed ID: 15617826
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
33. Zeta potential: a case study of cationic, anionic, and neutral liposomes.
Smith MC; Crist RM; Clogston JD; McNeil SE
Anal Bioanal Chem; 2017 Sep; 409(24):5779-5787. PubMed ID: 28762066
[TBL] [Abstract][Full Text] [Related]
34. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
[TBL] [Abstract][Full Text] [Related]
35. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
36. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.
Mourtas S; Papadia K; Kordopati GG; Ioannou PV; Antimisiaris SG; Tsivgoulis GM
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015274
[TBL] [Abstract][Full Text] [Related]
38. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
[TBL] [Abstract][Full Text] [Related]
39. Application of purging biotinylated liposomes from plasma to elucidate influx and efflux processes associated with accumulation of liposomes in solid tumors.
Fung VW; Chiu GN; Mayer LD
Biochim Biophys Acta; 2003 Apr; 1611(1-2):63-9. PubMed ID: 12659946
[TBL] [Abstract][Full Text] [Related]
40. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.
Bayer AM; Alam S; Mattern-Schain SI; Best MD
Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
